Related Experiment Video
Updated: May 1, 2026

06:48
The HoneyComb Paradigm for Research on Collective Human Behavior
Published on: January 19, 2019
10.9K
Emergence of a snake-like structure in mobile distributed agents: an exploratory agent-based modeling approach
1Bahria University, Islamabad 44000, Pakistan ; COSIPRA Lab, Computing Science & Mathematics, School of Natural Sciences, University of Stirling, Stirling FK9 4LA, UK.
Thescientificworldjournal
|April 5, 2014
Summary
This study introduces an agent-based algorithm for resilient, dynamic snake-like structures. The approach enables life-like animations and adaptable robots with minimal computational needs.
Area of Science:
- Robotics
- Artificial Intelligence
- Complex Systems
Background:
- Natural snake bodies exhibit resilience and adaptability due to numerous components.
- Current artificial snake-like structures use fewer components, limiting their flexibility and requiring intensive computation.
- Existing animations often lack life-like resilience and adaptive capabilities.
Purpose of the Study:
- To address limitations in modeling and animating snake-like structures.
- To propose a novel agent-based, self-organizing algorithm for dynamic and resilient artificial systems.
- To explore applications in animation and robotics.
Main Methods:
- Development of an agent-based, self-organizing algorithm.
- Simulation experiments to evaluate the algorithm's effectiveness and resilience.
- Exploratory agent-based modeling (EABM) for complex adaptive systems.
Main Results:
- The proposed algorithm generates emergent, resilient dynamic structures.
- Minimal inter-agent communication is required for the system's operation.
- Simulations confirm the approach's effectiveness and resilience.
Conclusions:
- The algorithm provides a solution for creating life-like, resilient snake-like animations.
- Potential applications include developing complex, autonomous, and evolvable robots.
- Highlights the utility of EABM in engineering artificial complex adaptive systems.
Related Concept Videos
Multicompartment Models: Overview
712
Multicompartment models are mathematical constructs that depict how drugs are distributed and eliminated within the body. They segment the body into several compartments, symbolizing various physiological or anatomical areas connected through drug transfer processes such as absorption, metabolism, distribution, and elimination.
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
712
Mechanistic Models: Overview of Compartment Models
587
Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
587
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
333
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
333

